Home > Last Update News about sex life - sex life
  • Gilead Sciences And Merck & Co., Inc. Agree To Register And Distribute HIV Medication In Twelve Countries 2008-10-4 22:22:00
  • Gilead Sciences, Inc. (Nasdaq:GILD) and Merck & Co., Inc. (NYSE:MRK) announced that the companies have entered into an agreement through which Gilead will assume the lead role for the distribution of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg) in 12 c... < Detail >

  • 5-LOXIN(R) Proven To Reduce The Symptoms Of Osteoarthritis In New Human Study Published In Arthritis Research And Therapy 2008-10-4 22:22:00
  • PL Thomas (PLT), in alliance with Laila Nutraceuticals, India, jointly announced the publication of a new study using their exclusive dietary supplement ingredient, 5-LOXIN®. In the study, 5-LOXIN supplementation conferred clinically and statistically significant improvements in pain scores and ... < Detail >

  • Marler Clark Files Salmonella Saintpaul Lawsuit Against Wal-Mart 2008-10-4 22:22:00
  • The first lawsuit stemming from the Salmonella outbreak that has sickened 1,319 people, hospitalized 255 and caused the death of two in 43 states, the District of Columbia and Canada was filed today in the District Court of Montezuma County, Colorado. The complaint was filed on behalf of Delores, Co... < Detail >

  • MDRNA Announces Phase 2 Trial Of PYY(3-36) Does Not Meet Weight Loss Endpoint 2008-10-4 22:21:00
  • MDRNA, Inc. (Nasdaq: MRNA) announced results from a Phase 2 clinical trial evaluating PYY(3-36) Nasal Spray (PYY) for the treatment of obesity. The data indicate that PYY did not meet the primary efficacy endpoint of a dose response of weight loss vs. PYY dose, nor did PYY meet the secondary efficac... < Detail >

  • Preclinical Data Demonstrates Potential Of LX214 As Best-in-Class Topical Treatment For Chronic Inflammatory Diseases Of The Eye 2008-10-4 22:21:00
  • Lux Biosciences announced the presentation of preclinical data demonstrating the safety and pharmacokinetics of LX214 as a potential once-daily topical treatment for chronic inflammatory diseases of the eye. LX214 is a clear, micellar, topical formulation of voclosporin, a next-generation calcineuri... < Detail >

  • CDC Numbers: HIV Prevention In US A Failure; AHF Calls For $200M To Test 10M People 2008-10-4 22:21:00
  • These numbers are a scathing indictment of how profoundly U.S. and CDC HIV prevention efforts have failed, said Michael Weinstein, President of AIDS Healthcare Foundation, the U.S. largest AIDS organization, in a statement from Mexico City. Despite the way the CDC is spinning these new numbers - whi... < Detail >

  • Merck Responds To Aids Activists' Pleas; Reduces Price Of Stocrin By 40% In Mexico, Notes AHF 2008-10-4 22:21:00
  • As more than 20,000 people from around the world gather this weekend for the start of the XVII International AIDS Conference in Mexico City, AIDS Healthcare Foundation (AHF) the US-based NGO which provides HIV/AIDS medical care and/or services to more than 79,000 individuals in 20 countries w... < Detail >

  • Frost & Sullivan Honours TransPharma Medical For Its Innovative ViaDerm Drug Delivery System 2008-10-4 22:21:00
  • The 2008 Frost & Sullivan European Transdermal Drug Delivery Product Innovation Award is conferred on Israel-based TransPharma Medical Ltd. in recognition of its innovative ViaDerm drug delivery system. The company's two flagship drug product development programs - ViaDerm hPTH (1-34) for the... < Detail >

  • Nymox Has Global Patent Rights For Statin Drugs For The Treatment And Prevention Of Alzheimer's Disease 2008-10-4 22:21:00
  • Nymox Pharmaceutical Corporation (NASDAQ:NYMX) holds U.S. and global patent rights for the use of statin drugs for the prevention and treatment of Alzheimer's disease (AD), including for patients at risk for AD because of vascular-related risk factors or disease. An important new study has found tha... < Detail >

  • Scottish Study Adds Support For World-Wide Ban On Smoking In Public Places 2008-10-4 22:21:00
  • NHS Health Scotland, the national health improvement agency, has found a 17 per cent fall in admissions for heart attacks just one year after the smoking ban1 came into force.

    Undertaken by the University of Glasgow, this study is one of the most robust of its kind, and was commissioned as p... < Detail >

  • Leading Organisations Call For Recognition Of Palliative Care And Pain Treatment As Human Rights 2008-10-4 22:21:00
  • The International Association for Hospice and Palliative Care (IAHPC), the Worldwide Palliative Care Alliance (WPCA) and different organisations from around the world will issue today a Joint Declaration and Statement of Commitment calling for the recognition of Palliative Care and Pain Treatment as... < Detail >

  • July 2008 National Pharmacy Association Board Meeting, UK 2008-10-4 22:20:00
  • NPA (National Pharmacy Association) Chairman, Paul Bennett, comments on some of the items discussed at the July 2008 board meeting:

    1 NPA Strategic Purpose

    The NPA exists to serve members. Our purpose is to represent, support and protect the interests of all community pharmacy... < Detail >

  • China Becomes A Physics Powerhouse 2008-10-4 22:20:00
  • Judged by the astonishing increase in journal papers written by scientists in China, there can be little doubt that China is finding its place as one of the world's scientific power houses. Michael Banks, Physics World's News Editor, quantifies this surge in scientific output from China and a... < Detail >

  • An Environmental Study Into The Office Of The Future 2008-10-4 22:20:00
  • Mayo Clinic endocrinologist James Levine, M.D., Ph.D., has continued his research in environment-changing innovations with a six-month study of a real-life office that was re-engineered to increase daily physical activity or NEAT (non-exercise activity thermogenesis). The study began in late 2007 an... < Detail >

  • NIDDK Resource Helps Guide Women With Diabetes Through Healthy Pregnancies 2008-10-4 22:20:00
  • Pregnancy is a time of great excitement and anticipation. It also can be a time of anxiety, especially for women with type 1 or type 2 diabetes. Pregnancy in women who have diabetes is automatically considered high-risk. But a new, easy-to-read booklet has information to help women with diabetes exp... < Detail >

  • Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model 2008-10-4 22:20:00
  • In an animal model of multiple sclerosis (MS), neuroradiologists and neurologists of the University hospitals of Heidelberg and W眉rzburg have been able to visualize inflammatory tissue damage, most of which had remained unrecognized up to now, with the aid of a new contrast medium, Gadofluorine M, i... < Detail >

  • First National Study Of Diving-related Injuries - In Neighborhood Pools And Competitive Events, Diving Injuries Add Up, USA 2008-10-4 22:20:00
  • If it's at the Olympic Games or at the neighborhood pool, diving is one of the fastest growing sports in this country*. Every day millions of people do it* and every four years during the Olympics, billions of people watch it. So it might surprise you that researchers are just now delving into the d... < Detail >

  • American Cancer Society Study Finds High Use Of Complementary Methods Among Cancer Survivors 2008-10-4 22:20:00
  • A new study from researchers at the American Cancer Society finds many cancer patients use complementary and alternative methods, most often prayer, relaxation, supplements, meditation, and massage. Meanwhile, the use of other methods, such as biofeedback, homeopathy, and acupressure, are relatively... < Detail >

  • Immune System Protein Accurate Predictor Of Survival In Pediatric Septic Shock 2008-10-4 22:20:00
  • About 4,000 children in the United States die every year from uncontrolled infections of the body known as septic shock, and researchers are pushing the boundaries of molecular science to find new therapies that can stem the condition. But a simple measure of an immune system protein within 24 hours... < Detail >

  • Interferon Or Surgery For Eye Surface Cancer - Which Is Best? 2008-10-4 22:20:00
  • James Chodosh, MD, and colleagues evaluated 29 patients who were treated within a 10-year period for ocular surface squamous neoplasia (OSSN), a type of cancer, either by surgical removal of the tumor or with topical interferon (alfa-2b). There were no statistically significant differences in age, g... < Detail >

  • [1]  [2]   [3]   [4]   [5]   [6]   [7]   [8]   [9]   [10]   ... Last